Sertraline in the treatment of anxiety and agitation in children with autistic disorder

Downloads

Published

1998-03-31

How to Cite

Gastaminza, X. (1998). Sertraline in the treatment of anxiety and agitation in children with autistic disorder . Revista De Psiquiatría Infanto-Juvenil, (1), 57–59. Retrieved from https://aepnya.eu/index.php/revistaaepnya/article/view/429

Issue

No. 1 (1998): January-March

Section

Book reviews

Authors

  • X. Gastaminza

Keywords:

autistic disorder, sertraline, treatment

Abstract

Autism is a psychodevelopmental disorder that affects 10 out of 10,000 children and affects multiple areas: language development, social interaction, symbolic play, memory, impulse control, and affect regulation. They are children who present the known need for immutability in their environment with an intolerance to change in their routines or in their environment. Intolerance that occurs with behavioral dysregulation in response to changes in your routine or in your environment, manifesting explosive anxiety reactions with: intense anxiety, irritability, or panic or agitation or other explosive behaviors.

Downloads

Download data is not yet available.

References

Rapin I. Autistic children. Diagnostic and clinic features (Review). Pediatrics 1991;87:751-60.

Kanner L. Autistic disturbances of affective context. Nervous Child 1943;2:217-50.

Volkmar FR, Cohen D. Current concepts. En: Volkmar FR, editor. Psychoses and Pervasive Developmental Disorders. Philadelphia: WB Saunders; 1994. p: 43-52.

Steingard RJ, Zimnitzky B, Demaso DR, Bauman Ml, Bucci JP. Sertraline treatment of Transition-associated Anxiety and Agitation in Children with Autistic Disorder. J Child Adolescent Psychopharmacology 1997;7(1):9-15. https://doi.org/10.1089/cap.1997.7.9

American Psychiatric Association: Diagnostic and Statistical manual of mental Disorders. 4a edición. Washington (DC): American Psychiatric Association; 1994.

Chigier E. Compliance and conflict in adolescent. Int J Adolescent Med Health 1997;9(2): 117-21. https://doi.org/10.1515/IJAMH.1997.9.2.117

Bühlmann U. Cumplimiento terapéutico por el adolescente. En: Sasot J, Moraga FA, eds. Psicopedlatría del adolescente. Aspectos preventivos y psicosociales. Barcelona: Prous; 1998. p. 239-46.

Tamaroff, MH, Festa RS, Adesman AR, et al. Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates. J Pediatr 1992; 120:812-7. https://doi.org/10.1016/S0022-3476(05)80257-4

Richters JE, Arnold LE, Jensen PS, et al. NIMH collaborative multisite multimodal treatment study of children with ADHD: I Background and rationale. J Am Acad Child Adolesc Psychiatry 1995;34:987-1000. https://doi.org/10.1097/00004583-199508000-00008

Elia J, Borchending BG, Rapoport JL, Keysor CS. Methylphenidate and Dextroamphetamine treatments of hiper- activity: are there true nonresponders? Psychiatry Res 1991; 36:141-155. https://doi.org/10.1016/0165-1781(91)90126-A

Gadow K.D. Pediatric psychopharmacotherapy: a review of recent research. J Child Psychol Psychiatry 1992;33:153-95. https://doi.org/10.1111/j.1469-7610.1992.tb00861.x

Weiss G, Hechtman LT. Medication treatment of ADHD. En: Weiss G, Hechtman LT, eds. Hiperactive Children Grow Up. 2a edición. New York, NY: Guilford Press; 1993. p. 348-65.

Efron D, Jarman F, Barker M. Side effects of Methylphenidate and Dexamphetamine in Children With Attention Deficit Hyperactivity Disorder: A Double-blind, Crossover Trial. Pediatrics 1997; 100(4):662-6. https://doi.org/10.1542/peds.100.4.662

Most read articles by the same author(s)

1 2 3 > >>